Related Experiment Videos
Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation
M Bielski1, R Yomtovian, H M Lazarus
1Department of Pathology, Ireland Cancer Center, University Hospitals of Cleveland, Case Western Reserve University, OH, USA.
Bone Marrow Transplantation
|January 7, 1999
Summary
Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation (HSCT) is linked to low megakaryocyte counts. This suggests impaired megakaryocyte differentiation, not platelet production issues, as the cause.
Area of Science:
- Hematology
- Transplantation Medicine
- Oncology
Background:
- Prolonged isolated thrombocytopenia, requiring platelet transfusions >90 days post-hematopoietic stem cell transplantation (HSCT), affects ~5% of patients.
- The pathophysiologic basis and bone marrow biopsy findings in prolonged isolated thrombocytopenia remain undefined.
- Understanding the causes of this condition is crucial for improving patient outcomes after HSCT.
Purpose of the Study:
- To systematically review bone marrow biopsies in patients with prolonged isolated thrombocytopenia post-HSCT.
- To define the pathophysiologic basis of prolonged isolated thrombocytopenia.
- To compare megakaryocyte counts in HSCT patients with and without prolonged isolated thrombocytopenia.
Main Methods:
- Retrospective review of 454 HSCT cases (1990-1995) to identify patients with prolonged isolated thrombocytopenia (n=12).
- Analysis of bone marrow core biopsies from these patients, focusing on megakaryocyte cellularity, morphology, and clustering.
- Comparison of megakaryocyte counts with age and disease-matched HSCT controls (n=11) and normal donors.
Main Results:
- Patients with prolonged isolated thrombocytopenia (3% incidence) showed significantly lower absolute megakaryocyte counts in bone marrow biopsies.
- This reduction was observed both before and >30 days after HSCT compared to controls.
- No significant differences were found in megakaryocyte size, nuclear-cytoplasmic ratios, clustering, or overall marrow cellularity.
Conclusions:
- Decreased megakaryocyte differentiation from stem cells, rather than ineffective platelet production or destruction, likely causes prolonged isolated thrombocytopenia post-HSCT.
- Low pre-HSCT megakaryocyte counts may serve as a prognostic indicator for developing this complication.
- Further research into megakaryopoiesis regulation post-HSCT is warranted.